"Breast Neoplasms, Male" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.
Descriptor ID |
D018567
|
MeSH Number(s) |
C04.588.180.260 C17.800.090.500.260
|
Concept/Terms |
Breast Neoplasms, Male- Breast Neoplasms, Male
- Breast Neoplasm, Male
- Male Breast Neoplasm
- Neoplasm, Male Breast
- Tumors, Breast, Male
- Neoplasms, Breast, Male
- Neoplasms, Male Breast
- Breast Tumors, Male
- Breast Tumor, Male
- Male Breast Tumor
- Male Breast Tumors
- Tumor, Male Breast
- Tumors, Male Breast
- Male Breast Neoplasms
Male Breast Cancer- Male Breast Cancer
- Cancer, Male Breast
- Breast Carcinoma, Male
- Carcinoma, Male Breast
- Male Breast Carcinoma
- Breast Cancer, Male
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms, Male".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms, Male".
This graph shows the total number of publications written about "Breast Neoplasms, Male" by people in this website by year, and whether "Breast Neoplasms, Male" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2003 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2009 | 2 | 0 | 2 |
2010 | 2 | 1 | 3 |
2011 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2018 | 2 | 0 | 2 |
2019 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Neoplasms, Male" by people in Profiles.
-
Williams AD, Ciocca R, Sabol JL, Carp NZ. The use of neoadjuvant therapy increases the rate of breast conservation in men with locally advanced breast cancer. Clin Breast Cancer. 2022 06; 22(4):343-358.
-
Hoda RS, Arpin Iii RN, Gottumukkala RV, Hughes KS, Ly A, Brachtel EF. Diagnostic Value of Fine-Needle Aspiration in Male Breast Lesions. Acta Cytol. 2019; 63(4):319-327.
-
Venigalla S, Carmona R, Guttmann DM, Jain V, Freedman GM, Clark AS, Shabason JE. Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men. JAMA Oncol. 2018 10 01; 4(10):e181114.
-
Cui Q, Kong D, Li Z, Ahiable P, Wang K, Wu K, Wu G. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis. Clin Breast Cancer. 2018 10; 18(5):e875-e882.
-
Moten AS, Jayarajan SN, Willis AI. Spindle cell carcinoma of the breast: a comprehensive analysis. Am J Surg. 2016 Apr; 211(4):716-21.
-
Vranic S, Gurjeva O, Frkovic-Grazio S, Palazzo J, Tawfik O, Gatalica Z. IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast. Appl Immunohistochem Mol Morphol. 2011 Oct; 19(5):413-6.
-
Dunn JD, Ellis PG, Fox JL, Klein I, Lopes M, Nash DB, Nishida L, Schwartzberg LS, Wong W. Payer and provider collaborations that improve quality outcomes in oncology. Manag Care. 2010 Nov; 19(11):35-40, 42.
-
Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, Bilalovic N, Lee LM, Gatalica Z. Adenoid cystic carcinomas of the breast have low Topo IIa expression but frequently overexpress EGFR protein without EGFR gene amplification. Hum Pathol. 2010 Nov; 41(11):1617-23.
-
Wheler J, Tsimberidou AM, Moulder S, Cristofanilli M, Hong D, Naing A, Pathak R, Liu S, Feng L, Kurzrock R. Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experience. Clin Breast Cancer. 2010 Feb; 10(1):46-51.
-
Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A. MicroRNA expression profiling of male breast cancer. Breast Cancer Res. 2009; 11(4):R58.